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Objectives: Multidrug-resistant tuberculosis (MDR-TB) is a global problem that
many countries are challenged with. Rapid and accurate detection of MDR-TB is
critical for appropriate treatment and controlling of TB. The aim of the present
study was to evaluate the TaqMan allelic discrimination without minor groove
binder (MGB) as a rapid, efficient, and low-cost method for detection of drug
resistant strains of Mycobacterium tuberculosis.
Methods: A total of 112 M. tuberculosis isolates from cases with diagnosed TB
were subjected to drug susceptibility testing (DST), using the proportion method.
Resistant isolates were tested for characterization of mutations in the rpoB and
KatG genes by TaqMan genotyping.
Results: Of 112 M. tuberculosis isolates for which DST was performed, three,
one, and two isolates were MDR, rifampin (RIF) resistant, and isoniazid (INH)
resistant, respectively. According to the threshold cycle (Ct) and curve pattern of
mutants, TaqMan probes detect all of the mutations in the analyzed genes (katG
315, AGC/ACC, rpoB 531, TCG/TTG, and rpoB 531, TCG/TGG).
Conclusion: The present study suggests that drug-resistant strains of M. tuber-
culosis can be detected by pattern’s curve or Ct with TaqMan probes without
MGB in real-time polymerase chain reaction (PCR).1. Introduction
Multidrug-resistant tuberculosis (MDR-TB) is a global
problemthatmanycountriesarechallengedwith.MDR-TB
is caused by strains of Mycobacterium tuberculosisizabadi).
ase Control and Prevention.
reativecommons.org/licensresistant to at least isoniazid (INH) and rifampin (RIF), the
main first-line anti-TB drugs [1]. Rapid and accurate
detection of MDR isolates is critical for appropriate treat-
ment and controlling of TB [2e4]. The culture method is
still the “gold standard” among other drug susceptibilityPublished by Elsevier Korea LLC. This is an open access article
es/by-nc-nd/4.0/).
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method is time consuming and takes several weeks to be
completed. Inrecentyears, severalmolecularmethodshave
beendeveloped fordetectionofmutations in rpoBandkatG
genes that cause resistance to INH and RIF [5e7]. Of these
methods, Cepheid Xpert MTB/RIF kit and the line probe
assayshavebeencommercialized [8,9].Theygiveusers the
opportunity to detect the resistant mutants rapidly, but at
very high cost. Therefore, it is not possible, particularly in
developing countries, to apply these methods extensively.
Thus, researches have been concentrated to introduce the
in-house methods to reduce the cost.
TaqMan allelic discrimination is a new technique for
detection of mutations. In this method, mutations even
single nucleotide polymorphisms (SNP) are detected
using TaqMan probe with Minor Groove Binder (MGB)
and AmpliTaq Gold DNA polymerase. The efficiency of
probe hybridization reduces whenever there are mis-
matches between a probe and allele. Moreover, Ampli-
Taq Gold DNA polymerase is more likely to displace
the mismatched probe rather than cleave it to release
reporter dye. Recently, Wada et al [10] used TaqMan
minor groove binder (MGB) probes for detection of
mutations in rpoB, katG, and embB genes of M.
tuberculosis.
In this study, we designed the primers and probes for
81-bp hot spot of the rpoB gene and codon 315 of katG
gene. Unlike most researches that used the TaqMan
allelic discrimination, we did not use the MGB for
designing of probes.
Our main purpose was to evaluate TaqMan allelic
discrimination without minor groove binder (MGB) for
rapid detection of drug-resistant strains of M.
tuberculosis.2. Materials and methods
2.1. Setting
This study was performed at the Tehran University of
Medical Sciences. A total of 112 isolates of M. tuber-
culosis cultured from TB patients were included in this
survey.
2.2. Drug susceptibility testing (DST)
Drug resistant isolates were identified among 112
isolates using proportion method on LowensteineJensen
(LJ) media [11].
2.3. DNA extraction
DNA was extracted from the bacterial colonies ac-
cording to the method of van Soolingen et al [12]. A
commercial DNA extraction kit (Invitek, Germany) was
used for extraction of DNA from clinical specimens.
The optical density of extracted DNA from standard
strain and clinical specimens was determined at 260 nm
using NanoDrop 1000 (Thermo Scientific, USA).2.4. TaqMan analysis
TaqMan probes and primers for detection of mutations
in rpoB and katG genes were designed using the Primer
Express program (Applied Biosystems, Foster City,
CA, USA) and were synthesized by Metabion (Mar-
tinsried, Germany). The primers and probes of rpoB gene
were F: 50-TCACACCGCAGACGTTGATC-30, R: 50-
CGTAGTGCGACGGGTGC-30, P1: 50-FAM-CAGCT-
GAGCCAATTCATGGACCAGA-BHQ-1-30 (Tm Z
67.2), and P2: 50-VIC-CACAAGCGCCGACTGTCGGC-
BHQ-1-30 (TmZ 68.1). The primers and probe of katG
gene were F: 50-GGGCTTGGGCTGGAAGA-30, R: 50-
GGAAACTGTTGTCCCATTTCG-30, and P: 50-FAM-
ACGCGATCACCAGCGGCA-BHQ-1-30 (TmZ 65.0).
The PCR reaction mixture was 1 reaction buffer
[50 mM KCl, 10 mM Tris-HCl (pH 9.0), 2 mM MgCl2],
2.5 mM of dNTPs, 2 U Taq DNA-polymerase (miTaq,
Metabion, Martinsried, Germany), and 20 pmol each of
primers in total volume of 50 mL. Amplification was
performed in a Mastercycler Gradient (Eppendorf,
Germany) using the following program: initial dena-
turation at 95C for 10 minutes and 35 cycles of dena-
turation at 94C for 25 seconds, annealing at 60C for 30
seconds, and extension at 72C for 30 seconds, and the
final extension at 72C for 5 minutes. After amplifica-
tion, PCR products were sequenced.
The mixture of real-time PCR reaction was done
using TaqMan Genotyping Master Mix (Applied Bio-
systems) and the mentioned primers and probes. The
real-time PCR apparatus (Bioer, Hangzhou, and P.R.,
China) was programmed as follows: initial denaturation
at 94C for 10 minutes followed by 40 cycles of 94C
for 25 seconds, 60C for 55 seconds. To obtain repro-
ducibility of reaction, the amplification was run in
triplicate on DNA obtained from H37Rv strain, myco-
bacterial isolates, and clinical samples. All samples were
run with the DNA obtained from H37Rv strain. Human
white blood cell DNA and beta actin gene were used as
external and internal controls, respectively [13]. Diluted
DNA of H37Rv was used for the evaluation of the
sensitivity. Specificity of the reaction was evaluated on
DNA from other mycobacteria and potentially patho-
genic bacteria in the respiratory tract and human cells
that was used in the previous study [14].3. Results
Of 112 isolates, three, one, and two were MDR, RIF
resistant and INH resistant, respectively. The results of
sequencing of rpoB and katG genes are shown in Table
1. Fig. 1 shows the analysis of DNA from mycobacteria
with TaqMan probes. As described above, AmpliTaq
Gold DNA polymerase could detect the mismatches
between a probe and allele even SNP. According the
figure, the pattern curve of H37Rv strain is different
from the mutants. Moreover, the luminescence intensity
Table 1. Results of sequencing of 81-bp hot spot of the
rpoB gene and codon 315 of the katG gene.
Phenotypic characteristic
of resistant isolates
Genotypic characteristic
of resistant isolates
Resistant to INH katG 315, AGC/ACC
Resistant to RIF rpoB 531, TCG/TTG
rpoB 531, TCG/TGG
INHZ isoniazid; RIFZ rifampin.
Rapid detection of multidrug-resistant Mycobacterium tuberculosis 129or threshold cycle (Ct) was higher when mutations were
present in the genes. The difference of curve patterns
can differentiate the susceptible and resistance isolates.
Therefore real-time PCR detected the all of the muta-
tions in rpoB and katG genes.
With the exception of M. tuberculosis complex (M.
bovis, M. bovis, BCG, M. africanum, and M. microti), no
luminescence was found. The results of PCR in serial
dilutions demonstrated high efficiency of the technique
as it detected 10 pg of M. tuberculosis DNA.4. Discussion
Real-time PCR system in combination with MGB
probes has been applied to analyze single-nucleotideFigure 1. The curve patterns of H37Rv strain, negative control an
315, AGC/ACC mutation.polymorphisms [10,15]. The MGB probes have been
used in other studies for detection and distinction of one-
base mismatches due to their high specificity and
sensitivity [16], so it can be a powerful tool for control
of drug-resistant M. tuberculosis. In this study, we
developed a rapid, efficient, and low-cost real-time
PCR-based system without MGB probes for detection of
the mutations associated with INH and RIF resistance in
M. tuberculosis.
Despite our probes detecting all mutations in the
mentioned regions of the katG and rpoB genes as little
as 3 hours from the preparation of DNAs from clinical
samples, our method had limitation in use because it
could not identify MDR and XDR strains that geneti-
cally belonged to the Harrlem3 and Harrlem4 clusters
in spoligotyping. Interestingly, there were no muta-
tions in the 81-bp hot spot of the rpoB gene and codon
315 of katG gene of these strains as determined by
DNA sequencing (data not shown). Therefore, the
result of this study gives evidence that a single mo-
lecular method for detection of drug-resistant M.
tuberculosis is not sufficient. In comparison with the
conventional and commercial methods (i.e., line
probes or Cepheid Xpert MTB/RIF kit) for detection of
MDR-TB, our in-house technique was less time- and
fund-consuming, with costs five times cheaper than
commercial kits.d Mycobacterium tuberculosis mutants with and without katG
130 D. Darban-Sarokhalil, et alMany studies used real-time PCR for detection of
mutations in rpoB and katG genes [17e21] but, to our
knowledge, this study is the first one that uses the
TaqMan allelic discrimination without MGB. Our study
suggests that drug-resistant M. tuberculosis can be
detected by pattern’s curve or Ct with TaqMan probes
without MGB in real-time PCR. We evaluated our
probes on limited resistant M. tuberculosis isolates
(katG 315, AGC/ACC, rpoB 531, TCG/TTG and
rpoB 531, TCG/TGG), and the mentioned mutations
are the common mutations that cause RIF- and INH-
resistant strains. However, for more confirmation,
evaluation of other mutations in the 81-bp hot spot of
the rpoB gene as well as more drug-resistant strains is
needed.
Conflicts of interest
All authors have no conflicts of interest to declare.
Acknowledgments
This work is a part of project 9627 supported by
Tehran University of Medical Sciences.
References
1. Nasiri MJ, Dabiri H, Darban-Sarokhalil D, et al. Prevalence of
drug-resistant tuberculosis in Iran: systematic review and meta-
analysis. Am J Infect Control 2014 Sep;42(11):1212e8.
2. Ade´kambi T, Colson P, Drancourt M. rpoB-based identification of
nonpigmented and late-pigmenting rapidly growing mycobacteria.
J Clin Microbiol 2003 Dec;41(12):5699e708.
3. Palomino JC. Molecular detection, identification, and drug resis-
tance detection in Mycobacterium tuberculosis. FEMS Immunol
Med Microbiol 2009 Jul;56(2):103e11.
4. Catanzaro A, Rodwell TC, Catanzaro DG, et al. Performance
comparison of three rapid tests for the diagnosis of drug-resistant
tuberculosis. PLoS One 2015 Aug 31;10(8):e0136861.
5. Marı´n M, De Viedma DG, Ruı´z-Serrano MJ, et al. Rapid direct
detection of multiple rifampin and isoniazid resistance mutations
in Mycobacterium tuberculosis in respiratory samples by real-
time PCR. Antimicrob Agents Chemother 2004 Nov;48(11):
4293e300.
6. Sali M, De Maio F, Caccuri F, et al. Multicenter evaluation of the
Anyplex Plus MTB/NTM MDR-TB assay for rapid detection of
Mycobacterium tuberculosis complex and multidrug-resistant
isolates in pulmonary and extrapulmonary specimens. J Clin
Microbiol; 2015 Oct. pii: JCM.01904-15.7. Mani V, Wang S, Inci F, et al. Emerging technologies for moni-
toring drug-resistant tuberculosis at the point-of-care. Adv Drug
Deliv Rev 2014 Nov;78:105e17.
8. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular
detection of tuberculosis and rifampin resistance. N Engl J Med
2010 Sep;363(11):1005e15.
9. World Health Organization (WHO). Molecular line probe assays
for rapid screening of patients at risk of multidrug-resistant
tuberculosis (MDR-TB). Policy statement 2008.
10. Wada T, Maeda S, Tamaru A, et al. Dual-probe assay for rapid
detection of drug-resistant Mycobacterium tuberculosis by real-
time PCR. J Clin Microbiol 2004 Nov;42(11):5277e85.
11. Nasiri MJ, Rezaei F, Zamani S, et al. Drug resistance pattern of
Mycobacterium tuberculosis isolates from patients of five prov-
inces of Iran. Asian Pac J Trop Med 2014 Mar;7(3):193e6.
12. van Soolingen D, De Haas PE, Hermans PW, et al. DNA finger-
printing of Mycobacterium tuberculosis. Methods Enzymol 1994;
235:196e205.
13. Mehndiratta M, Palanichamy JK, Ramalingam P, et al. Fluores-
cence acquisition during hybridization phase in quantitative real-
time PCR improves specificity and signal-to-noise ratio. Bio-
techniques 2008 Dec;45(6):625e6.
14. Darban-Sarokhalil D, Fooladi A, Bameri Z, et al. Cytochrome
CYP141: a new target for direct detection of Mycobacterium
tuberculosis from clinical specimens. Acta Microbiol Immunol
Hung 2011 Sep;58(3):211e7.
15. van Doorn HR, Claas EC, Templeton KE, et al. Detection of a
point mutation associated with high-level isoniazid resistance in
Mycobacterium tuberculosis by using real-time PCR technology
with 30-minor groove binder-DNA probes. J Clin Microbiol 2003
Oct;41(10):4630e5.
16. Kutyavin IV, Afonina IA, Mills A, et al. 30-Minor groove binder-
DNA probes increase sequence specificity at PCR extension
temperatures. Nucleic Acids Res 2000 Jan 15;28(2):655e61.
17. de Viedma DG, Infantes MdSD, Lasala F, et al. New real-time
PCR able to detect in a single tube multiple rifampin resistance
mutations and high-level isoniazid resistance mutations in
Mycobacterium tuberculosis. J Clin Microbiol 2002 Mar;40(3):
988e95.
18. Ramirez MV, Cowart KC, Campbell PJ, et al. Rapid detection of
multidrug-resistant Mycobacterium tuberculosis by use of real-
time PCR and high-resolution melt analysis. J Clin Microbiol
2010 Nov;48(11):4003e9.
19. Haeili M, Fooladi A, Bostanabad S, et al. Rapid screening of rpoB
and katG mutations in Mycobacterium tuberculosis isolates by
high-resolution melting curve analysis. Indian J Med Microbiol
2014 OcteDec;32(4):398e403.
20. Choi GE, Lee SM, Yi J, et al. High-resolution melting curve
analysis for rapid detection of rifampin and isoniazid resistance in
Mycobacterium tuberculosis clinical isolates. J Clin Microbiol
2010 Nov;48(11):3893e8.
21. Park S-H, Kim C-K, Jeong H-R, et al. Evaluation and comparison
of molecular and conventional diagnostic tests for detecting
tuberculosis in Korea, 2013. Osong Public Health Res Perspect
2014 Dec;5(Suppl.):S3e7.
